Oncotelic Therapeutics, Inc. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Oncotelic Therapeutics, Inc. (OTLC) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 68.68 thousand shares for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2024-04-12
- Oncotelic Therapeutics, Inc. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2022 was 68.68K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|
| 2022-12-31 | 68.68K shares 10-K · filed 2024-04-12 |